Vossius C, Nilsen OB, Larsen JP (2009) Health state values during the first year of drug treatment in early-stage Parkinson’s disease: a prospective, population-based, cohort study. Drugs Aging 26:973–980Vossius C, Nilsen OB, Larsen JP. Health state values during the first year of drug...
“Parkinson’s disease and progressive supranuclear palsy are devastating diseases and this important step of dosing the first healthy volunteer with ARV-102 marks a significant milestone in our commitment to develop transformative therapies...
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 2006;5:911-916.Fung HC, Scholz S, Matarin M, Simo´ n-Sa´nchez J, Hernandez D, Britton A, Gibbs JR, Langefeld C, Stiegert ML, Schymick...
Health state values during the first year of drug treatment in early-stage Parkinson’s disease: a prospective, population-based, cohort study. Drugs Aging - Vossius, OB, et al.Vossius C, Nilsen OB, Larsen JP. Health state values during the first year of drug treatment in early-stage ...
Predictors of anxiety in early-stage Parkinson's disease--Results from the first two years of a prospective cohort study. Parkinsonism Relat. Disord. 2017, 43, 49-55. [CrossRef] [PubMed]Rutten S, van der Ven PM, Weintraub D, Pontone GM, Leentjens AFG, Berendse HW, et al. ...
First of all, the frozen and unstained tissue section was left to thaw at room temperature. Measurements were also carried out at room temperature. No immersion medium between the sample surface and the microscope objectives was used. The microscope stage, the camera, as well as the spectrometers...